Caribou Biosciences CRBU
NASDAQ CRBU
$0.56 +0.02 (+2.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Total Debt (2020)

Updated

Caribou Biosciences (CRBU) recorded Total Debt of $924,000 in Q4 2020.

Analysis

Caribou Biosciences (CRBU) Total Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Caribou Biosciences 56.06 Mn -460.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 924,000.00
API Access

Caribou Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=CRBU&period=max&api_key=YOUR_API_KEY